Reports

To assist health care providers, policy-makers, and consumers in making well-informed decisions about the prescribing and use of insulin analogues, our completed research and resulting recommendations are available in a series of Optimal Therapy Reports that provide:

• evidence-based clinical statements and cost-effectiveness statements
• a clear picture of current practice in Canada regarding the use of insulin analogues
• an analysis of the quantity of insulin agents prescribed, including market share and cost information
• an outline of gaps between current prescribing and use.

Summary Reports

• Project in Brief (one-page synopsis of clinical reports)
• Executive Summary (eight-page synopsis of clinical reports)

Final Reports

• Canadian Agency for Drugs and Technologies in Health. Optimal Therapy Recommendations for the Prescribing and Use of Insulin Analogues. Optimal Therapy Report – COMPUS 2009;2(7).
• Canadian Agency for Drugs and Technologies in Health. Gap Analysis and Key Messages for the Prescribing and Use of Insulin Analogues. Optimal Therapy Report – COMPUS 2008;2(8).
• Long-Acting Insulin Analogues for the Treatment of Diabetes Mellitus: Meta-analyses of Clinical Outcomes — Update of CADTH Technology Report No. 92. Optimal Therapy Report – COMPUS 2008;2(1).
• Summary of Revisions
• Canadian Agency for Drugs and Technologies in Health. Rapid-Acting Insulin Analogues for the Treatment of Diabetes Mellitus: Meta-analyses of Clinical Outcomes. Update of CADTH Technology Report No. 87. Optimal Therapy Report – COMPUS 2008;2(2).
• Canadian Agency for Drugs and Technologies in Health. GRADE Evidence Profiles on Long- and Rapid-Acting Insulin Analogues for the Treatment of Diabetes Mellitus. Optimal Therapy Report – COMPUS 2008;2(3).
• The Canadian Agency for Drugs and Technologies in Health. An Economic Evaluation of Insulin Analogues for the Treatment of Patients with Type 1 and Type 2 Diabetes Mellitus in Canada. Optimal Therapy Report − COMPUS 2008;2(4).
• The Canadian Agency for Drugs and Technologies in Health. Current Utilization of Insulin Products in Canada. Optimal Therapy Report − COMPUS 2008;2(5).
• Canadian Agency for Drugs and Technologies in Health. Current Practice Analysis: Insulin Analogues. A Qualitative Analysis of Canadian Physician Perceptions and Use of Insulin Analogues. Optimal Therapy Report – COMPUS 2008;2(6).